Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) over five years over Washington's insistence on confidential data.
The decision came to light following a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesman later clarified that the US was demanding access to genetic material for scientific study and profit while was not willing to share the benefits from future treatments.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued dialogue to find a agreement suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
After returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.
Based on reports, 16 African countries have so far signed similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for scientific discovery with no assurance that the end products would be available to our people should a new disease outbreak arise."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks previously set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This framework is designed to guarantee that when a nation provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We encourage continued dialogue with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist given that much of the country's Aids initiatives were funded by external financing.
"If specific concerns arise, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.
The halted deal highlights the ongoing debate between accepting vital international aid and protecting local interests in an ever more interconnected world.